John Sperzel III Net Worth & Insider Trades
John Sperzel III - Chairman and CEO, T2 Biosystems, Inc
What is John Sperzel III's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Chairman and CEO, John Sperzel III, is estimated to be about $324.63K . John Sperzel III owns about 17,329 units of T2 Biosystems, Inc common stock. In the last 2 years at T2 Biosystems, Inc, John Sperzel III has sold an estimated value of $69.71K worth.
What is John Sperzel III's Past Insider Trading?
John Sperzel III's largest purchase order was 30,000 units , worth over $15K on April 11, 2022. John Sperzel III's largest sale order was 9,773 units , worth over $6.18K on March 9, 2023. In total, John Sperzel III has made about 5 transactions over 2 years of their time at T2 Biosystems, Inc. John Sperzel III usually trades in February, with the busiest year in 2022.
John Sperzel III
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was John Sperzel III's Salary in 2020?
As Chairman and CEO of T2 Biosystems, Inc, John Sperzel III has a total base salary of $72,906 . John Sperzel III received compensation valued at about $1,170,087 in 2020 after becoming Chairman and CEO. The vast majority of their compensation came in the form of stock awards of $74,999 , other compensation of $1,022,182 .
What is John Sperzel III's' Mailing Address?
- Mailing address is 61 Crestview Lane Brunswick ME 04011 ME
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on March 9, 2023 by Brett Giffin who sold 537 units worth $349.05 . In the last 9 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.1M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, David Elsbree, Director, and Terrence Michael Gibbs, General Counsel .
T2 Biosystems, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||